Skip to main content
Sonova Holding AG logo

Sonova Holding AG — Investor Relations & Filings

Ticker · SOON ISIN · CH1180512795 LEI · 5299004A0QNX7FBNHS61 SW Manufacturing
Open in API
Filings indexed 116 across all filing types
Latest filing 2022-03-29 Transaction in Own Shar…
Country CH Switzerland
Listing SW SOON

About Sonova Holding AG

https://www.sonova.com/en

Sonova Holding AG is a global provider of hearing care solutions. The company develops, manufactures, and distributes a wide range of products and services through four core businesses: Hearing Instruments, Audiological Care, Consumer Hearing, and Cochlear Implants. Its portfolio includes hearing aids, cochlear implants, personal audio devices, and wireless communication systems, complemented by professional audiological care services. Sonova operates through a multi-brand strategy, with core brands such as Phonak, Unitron, Advanced Bionics, AudioNova, and Sennheiser (under license), serving a global consumer base in more than 100 countries.

Recent filings

Filing Released Lang Actions
Sonova concludes 2021-22 share buyback and will start a new three-year buyback program of up to CHF 1.5 billion
Transaction in Own Shares Classification · 100% confidence The document is explicitly labeled as an 'Ad-hoc announcement pursuant to Art. 53 LR' and details the conclusion of a share buyback program and the initiation of a new one up to CHF 1.5 billion. This type of announcement, concerning significant corporate actions like share repurchases, is typically classified under Capital/Financing Update (CAP) or, given the specific focus on share transactions, Transaction in Own Shares (POS). Since the core subject is the execution and announcement of a share buyback program (Transaction in Own Shares), POS is the most precise fit. It is not a full financial report (10-K or IR), nor is it just a general announcement of a report (RPA).
2022-03-29 English
Judgment in patent infringement case Advanced Bionics files appeal
Regulatory Filings Classification · 95% confidence The document is explicitly labeled as an "Ad-hoc announcement pursuant to Art. 53 LR" and discusses a specific legal matter: a judgment in a patent infringement case and the subsequent appeal filed by Advanced Bionics. This type of material, which reports on significant, non-routine events that could affect the stock price, falls under the category of general regulatory announcements or material event disclosures. Since there is no specific category for 'Legal Proceedings Report' that covers ad-hoc announcements of litigation updates, and it is not a standard periodic report (10-K, IR, ER), the most appropriate classification is the general regulatory filing category, RNS (Regulatory Filings), which serves as a fallback for miscellaneous, material announcements not covered elsewhere. The document length is moderate (5656 chars), but its nature is a direct disclosure of a material event, not an announcement *about* a report.
2022-03-08 English
Sonova completes acquisition of the Sennheiser Consumer Division and forms a new business
M&A Activity Classification · 99% confidence The document is explicitly labeled as an "Ad-hoc announcement pursuant to Art. 53 LR" and details the successful completion of a major acquisition (Sonova completing the acquisition of the Sennheiser Consumer Division). This type of material event disclosure, which is not a standard periodic report (like 10-K or IR) or a specific shareholder action (like DIV or DVA), falls best under the general category for regulatory announcements that are material and time-sensitive. Since it is a significant corporate event disclosure required by listing rules (Art. 53 LR), and it doesn't fit the specific definitions for M&A (TAR - which usually implies a proposal/bid), Capital (CAP), or Director changes (MANG), the most appropriate general category for a mandatory, non-standard regulatory disclosure is Regulatory Filings (RNS). It is a direct announcement of a material event, not an announcement *about* a report.
2022-03-01 English
Sonova completes acquisition of Alpaca Audiology
Regulatory Filings Classification · 95% confidence The document is titled 'News Details' and is explicitly labeled as an 'Ad-hoc announcement pursuant to Art. 53 LR'. It announces the successful completion of an acquisition (Sonova completes acquisition of Alpaca Audiology) and provides financial context related to that transaction. This type of material, which is a significant, non-scheduled corporate event disclosure, typically falls under general regulatory announcements or specific transaction/financing updates. Since it is not a full annual report (10-K), quarterly report (IR), earnings release (ER), or a specific management/board change, it best fits the general regulatory disclosure category. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for an ad-hoc announcement of a material event like an acquisition completion, especially when a more specific category like M&A Activity (TAR) is usually reserved for the proposal/bid phase, although this is a completion notice. However, since it is a specific corporate action announcement (acquisition completion), it is often classified under general regulatory news. RNS serves as the best fit for non-standard, mandatory disclosures that aren't standard periodic reports.
2022-03-01 English
Sonova to increase presence in US market: Acquisition of leading audiological care network
Regulatory Filings Classification · 95% confidence The document is titled 'News Details' and begins with 'Ad hoc announcement pursuant to Art. 53 LR'. It details a significant corporate action: the acquisition of Alpaca Audiology for USD 310 million. This type of material, which announces a major event like an acquisition, is typically classified as a significant corporate event announcement. Since the definitions provided do not have a specific 'M&A Announcement' code, I must evaluate the closest fit. The document is not a full financial report (10-K, IR), a management discussion (MDA), or a standard earnings release (ER). It is a material, non-scheduled announcement. The closest category that covers significant corporate actions not explicitly defined elsewhere, especially those related to financing or major structural changes, is often captured under general regulatory filings or specific transaction types. Given the options, this is a major corporate transaction announcement. While TAR is for M&A Activity, this document is the *announcement* of the transaction, not necessarily the formal tender offer documents. However, in the context of these specific codes, 'TAR' (M&A Activity) is the most appropriate fit for an acquisition announcement, as it directly relates to a merger/takeover proposal/activity, even if it's an acquisition rather than a bid. If TAR is strictly for takeover bids, the next best fit would be RNS (Regulatory Filings) as a general announcement. Given the prominence of the acquisition, TAR is superior to RNS. The document length (6748 chars) is substantial enough that it is the primary announcement, not just a brief notice of publication (RPA).
2022-01-13 English
Sonova nominates Julie Tay for election as a new member of the Board of Directors
Board/Management Information Classification · 100% confidence The document is a 'Media Release' dated December 15, 2021, announcing that the Board of Directors will nominate Julie Tay for election as a new member at the next Annual General Meeting (AGM) in June 2022. This content directly relates to changes in the company's board of directors and senior management structure. This aligns perfectly with the definition for Board/Management Information (MANG). It is not an AGM presentation (AGM-R), a formal regulatory filing like 10-K, or an earnings release (ER).
2021-12-15 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.